A double-blind, placebo-controlled, dose-escalation trial of pimavanserin in Parkinson's disease and psychosis

被引：0
|
作者：
Revell, Stephen
Friedman, Joseph
Mills, Roger G.
Williams, Hilde
Johnson, Ann D.
Bahr, Daun
机构：
来源：
NEUROLOGY | 2008年 / 70卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A284 / A285
页数：2
相关论文
共 50 条
  • [1] A double-blind, placebo-controlled, dose-escalation trial of pimavanserin in Parkinson's disease and psychosis
    Mills, R.
    Revell, S.
    Bahr, D.
    Williams, H.
    Johnson, A.
    Friedman, J. H.
    MOVEMENT DISORDERS, 2008, 23 (01) : S221 - S222
  • [2] A multi-center, placebo-controlled, double-blind trial to examine the safety and efficacy of pimavanserin in the treatment of psychosis in Parkinson's disease
    Friedman, J. H.
    Ravina, B.
    Mills, R.
    Williams, H.
    Bahr, D.
    Peters, P.
    Tison, F.
    Burn, D.
    MOVEMENT DISORDERS, 2010, 25 (07) : S292 - S292
  • [3] A multi-centre, placebo-controlled, double-blind trial to examine the safety and efficacy of pimavanserin in the treatment of psychosis in Parkinson's disease
    Friedman, J. H.
    Ravina, B.
    Mills, R.
    Williams, H.
    Revell, S.
    Bahr, D.
    Tison, F.
    Burn, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 656 - 656
  • [4] A Multi-Center, Placebo-Controlled, Double-Blind Trial To Examine the Safety and Efficacy of Pimavanserin in the Treatment of Psychosis in Parkinson's Disease
    Friedman, Joseph
    Ravina, Bernard
    Mills, Roger
    Williams, Hilde
    Bahr, Daun
    Peters, Perry
    Tison, Francois
    Burn, David
    NEUROLOGY, 2010, 74 (09) : A299 - A299
  • [5] Kava extract in Huntington's disease: A double-blind, placebo-controlled, dose-escalation crossover study
    Hogarth, P.
    Crossen, E.
    MOVEMENT DISORDERS, 2006, 21 : S442 - S443
  • [6] A Prospective, Randomized, Placebo-Controlled Double-Blind, Dose-Escalation Trial of Pyridostigmine for Diabetes Mellitus and Constipation
    Bharucha, Adil F.
    Low, Phillip A.
    Camilleri, Michael
    Burton, Duane D.
    Kudva, Yogish C.
    Shah, Pankaj
    Zinsmeister, Alan R.
    GASTROENTEROLOGY, 2011, 140 (05) : S2 - S3
  • [7] Subcutaneous apomorphine in patients with advanced Parkinson's disease: A dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose
    Pahwa, Rajesh
    Koller, William C.
    Trosch, Richard M.
    Sherry, James H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 258 (1-2) : 137 - 143
  • [8] A Randomized, Double-Blind, Placebo-Controlled Trial of Camicinal in Parkinson's Disease
    Marrinan, Sarah L.
    Otiker, Tal
    Vasist, Lakshmi S.
    Gibson, Rachel A.
    Sarai, Bhopinder K.
    Barton, Matthew E.
    Richards, Duncan B.
    Hellstrom, Per M.
    Nyholm, Dag
    Dukes, George E.
    Burn, David J.
    MOVEMENT DISORDERS, 2018, 33 (02) : 329 - 332
  • [9] Quetiapine for drug-induced psychosis in Parkinson's disease: A double-blind, placebo-controlled, parallel trial
    Ondo, WG
    Vuong, KD
    Ringholz, G
    MOVEMENT DISORDERS, 2003, 18 (09) : 1083 - 1084
  • [10] Abciximab in acute ischemic stroke - A randomized, double-blind, placebo-controlled, dose-escalation study
    Adams, HP
    Bogousslavsky, J
    Barnathan, E
    Brott, T
    Fisher, M
    Furlan, AJ
    Graffagnino, C
    Kappelle, J
    Kothari, R
    Leclerc, JR
    Moulin, T
    Polzer, J
    Torner, J
    Worley, S
    Haley, CE
    Day, JH
    Levine, SR
    Thompson, JLP
    Sherman, DG
    Sane, DC
    Maley, JE
    Grimsman, KJ
    Maeder, M
    Clarke, WR
    Anderson, K
    Cook, R
    FitzPatrick, S
    Peeters, A
    Cras, P
    Blecic, S
    Laloux, P
    Chatel, M
    Mahagne, H
    Moulin, T
    Hacke, W
    Diener, HC
    Bogousslavsky, J
    Maeder, M
    Kappelle, LJ
    Vermulen, M
    Kwa, VIH
    Franke, CL
    Jacoby, M
    Libman, R
    Hsu, C
    Kothari, R
    Raps, EC
    Kasner, SE
    Scott, P
    Karanjia, P
    STROKE, 2000, 31 (03) : 601 - 609
12345